OCT 04, 2016 8:00 AM PDT

Overcoming the Clinical Sample Bottleneck for Expression Studies

Sponsored by: Affymetrix, Affymetrix
Speakers
  • Helene Roberson Professor of Pediatrics, Washington University School of Medicine
    BIOGRAPHY
  • Assistant Professor, Department of Medicine-Infectious Disease; Associate Director, Vaccine Testing Center, University of Vermont College of Medicine
    BIOGRAPHY

Abstract
DATE:  October 4, 2016
TIME:  8:00am PT, 11:00am ET

Extracting robust expression data from clinical samples represents a unique opportunity to find actionable biomarkers. But it does not come without challenges. Clinical samples such as whole blood and feces are technically challenging to work with, often of poor quality, and provide limited amounts of high-quality RNA making it difficult to generate reproducible and informative expression data.
 
Feces, in particular, are increasingly identified as useful non-invasive samples for molecular diagnosis of infectious disease, but their composition consists of a complex microbial community making the identification of human RNA signatures problematic. Whole blood is also a desirable sample type as it is widely available and collection is relatively non-invasive and inexpensive. Yet 70% of mRNA in whole blood is globin mRNA released from red blood cells, introducing noise and decreasing the sensitivity for detecting relevant transcripts. Most expression technologies require the removal of globin mRNA from the sample before processing, a time-consuming and costly step that introduces bias. Due to such challenges, researchers are demanding better expression methods for use with clinical samples, like whole blood and feces.
 
Choosing the right transcriptome profiling tool compatible with clinical samples is key to generating informative biomarkers that can be used to improve human health.
 
During this webinar, leading translational researchers will:
  • Demonstrate how novel transcriptome profiling assays can reliably identify biomarkers from even the most challenging of samples including feces.
  • Explain how to generate robust expression data from small amounts of whole blood without the need to eliminate globin mRNA, saving time and money while retaining data integrity.
  • Discuss the importance of choosing the right technology to obtain reliable data from rare samples while still preserving material for future use.  
  • Answer your questions live during the broadcast!

For Research Use Only. Not for use in diagnostic procedures. 

Show Resources
You May Also Like
FEB 15, 2023 7:00 AM PST
FEB 15, 2023 7:00 AM PST
Date: February 15, 2023 Time: 7:00am (PST), 10:00pm (EST), 4:00pm (CET) While not all microscopy samples can fluoresce, all can scatter light, and this scattered light can be imaged. This ha...
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
C.E. CREDITS
Date: October 25, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CEST) Candida auris is a multi-drug resistant yeast that continues to be a global threat for infection and transmission in h...
OCT 12, 2022 9:00 AM PDT
C.E. CREDITS
OCT 12, 2022 9:00 AM PDT
Date: October 12, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) The microbiome of every food product is incredibly diverse and can include everything from innocuous background flora...
SEP 13, 2022 8:00 AM PDT
SEP 13, 2022 8:00 AM PDT
Date: September 13, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Preparedness against pandemic diseases demands rapid-response vaccine technology and ready-to-use analytical methods...
Loading Comments...
Show Resources